Internal Medicine - Issue 4/2021
Editorial
Main Topic
201
206
Biologic therapy for dyslipidemia
David Karásek
Original Contributions
212
Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment
Jana Čepelová, Marek Malý, Josef Daněk, Martin Malý
Review Articles
218
Importance and efficiency of blood pressure control not only in type 2 diabetes patients
Veronika Vejtasová, Jana Urbanová, Ludmila Brunerová, Michala Lustigová, Michael Jenšovský, Barbora Prýmková, Sabina Pálová, Jan Brož
224
Giant cell arteritis: controversial issues
Štefan Alušík
230
Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020–2021 Czech Pneumological and Phthiseological Society position paper
doc. MUDr. Kristián Brat, Ph.D., Jaromír Zatloukal, Kateřina Neumannová, MUDr. Eva Voláková, Ph.D., Ondřej Kudela, Michal Kopecký, Marek Plutinský, Vladimír Koblížek
Case reports
240
Thymoma – disease of many faces
Kateřina Pokorná, Vladimír Kojecký
244
Internal Medicine
2021 Issue 4
Most read in this issue
- Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020–2021 Czech Pneumological and Phthiseological Society position paper
- Thymoma – disease of many faces
- Targeted and biological drugs in the treatment of inflammatory rheumatic diseases
- Biologic therapy for dyslipidemia